GlassScriptPhysician profile
Jaime Rene Chavez
NPI 1689822678
$7,225.85
in general payments reported to CMS, 2019-2025
32 companies · $1,248 in 2025
The $1,248 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $617 · 2021: $695 · 2022: $763 · 2023: $1,336 · 2024: $1,456 · 2025: $1,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,041.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,732.61 | 2019-2025 | Eluvia, Watchman Flx, Farapulse |
| Amgen INC. | $694.37 | 2019-2025 | Repatha, Repatha |
| Abiomed | $684.65 | 2019-2025 | Impella |
| Abbott Laboratories | $669.78 | 2019-2024 | Jeti Peripheral Catheter, Cardiomems, Aveir |
| Janssen Pharmaceuticals, INC | $394.49 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $391.10 | 2019-2025 | |
| Avinger INC. | $194.83 | 2019-2023 | Pantheris |
| Penumbra, INC. | $158.02 | 2022-2023 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $157.86 | 2019-2024 | Farxiga |
| Medtronic, INC. | $152.73 | 2022-2025 | Pulseselect, Affera Mapping System |
| Livanova USA, INC. | $147.54 | 2023 | Lifesparc |
| Edwards Lifesciences Corporation | $103.13 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $98.80 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Daxor Corporation | $92.59 | 2024 | Bva-100 |
| Cathworks, INC. | $78.03 | 2025 | Ffrangio |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $72.70 | 2022-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Biosense Webster, INC. | $66.15 | 2022-2023 | Carto 3 |
| Pfizer INC. | $56.95 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.57 | 2020-2023 | Lifevest |
| Angiodynamics, INC. | $31.11 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.99 | 2019-2023 | Jardiance |
| Irhythm Technologies, INC. | $26.92 | 2019-2020 | |
| Corindus INC. | $26.25 | 2019 | |
| Terumo Medical Corporation | $21.09 | 2025 | R2p Misago, Glidesheath Slender, Azur Cx Detachable |
| Microvention, INC. | $19.66 | 2024 | Eric Retrieval Device |
| Convatec INC. | $16.05 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.77 | 2023 | |
| Cordis US Corp. | $13.29 | 2023 | Selution Slrpta |
| Biotronik INC. | $13.07 | 2020 | |
| Chiesi USA, INC. | $11.98 | 2019 | |
| Gilead Sciences, INC. | $11.40 | 2019 | |
| Cvrx, INC. | $11.37 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.